It has been reported that ALL vaccines to be rolled out in 2025 will contain the deadly mRna component. This, despite the fact that in its experimental phase with animals, said experiments were stopped because of the high number of deaths. PLEASE eliminate mRna from ever being used in anything, stopping the evil, global genocidal plan in our country.
12 Likes
NO ONE SHOULD TAKE AN MRNA JAB PERIOD, if you do you are assigning your body to the Fauxcistein experiments of illness & disease. TRUMP should prohibit the use of them & roll back to 4 vaccines for children with No MRNA or Metals used as fillers or suspensions
I agree!!!
They should have full disclosures for all vaccines. Ban all MRNA, Spike Proteins, Nano Bots and any unnecessary chemicals and DNA altering substances and additives from all vaccines. We should have a full list of the ingredients and issues that could impact our bodies especially side effects and also if it was tested and the test results.
Absoultely spot on. Vaccines have been in use for decades, without mRNA technology introduced into them. Now that mRNA exists, the pharmaceuticals want to incorporate every shot they have into this new dangerous method.
Bottom line is that mRNA technology can easily become a threat to the entire Human Race, simply because it allows pharmaceutical companies access to the genetic material within the cells. Once the genetic material is altered/mutated, copies of that mutation are propagated throughout the cells life cycle, through mitotic division and continued cell replication.
Vaccines don’t need access to the interior genetic material of cells. We never needed it before. The drug companies want to push for everything to include mRNA tech. so because they want Pandora’s Box to remain wide open for any hair-brained genetic experiment that they wish to create. They stand to make trillions from mRNA, because it gives them access to human DNA – something that they didnt have before. All you need is one tiny mishap and the damage within the body is irreversable – the screw-up in genetic material will multiply like a cancer, and death will most likely be slow and agonizing, like any other cancer. Chemo-therapy would not work as a treatment, because the cells are not weak, they are simply genetically modified (wrongly of course). The whole idea of allowing mRNA for general public consumption is careless and potentially genocidal if mandatory mRNA shots are the the rule instead of the exception.
Eric, care to share a short description of the unnamed pdf file that you pushed up to google? Not everyone trusts pulling down and opening mystery files with no descriptions (esp. from google, and with a URL name to include “API” in it), onto their otherwise secure local machines, if you get my concern. Maybe some good old-fashioned text on what you are trying to share won’t set you back too much? Thanks.
Yes, the new mRNA vector can lead to hundreds of billions in new revenue for pharaceutical companies, because with mRNA, they now have unprecidended access to the genetic material within the cell.
Unfortunately, given the amount of exposure that the human populations that willingly take conventional vaccines, if the switchover to all of these vaccines incorporates new mRNA tech – and if there is even the slightest miscalculation, which alters genetic material in an unintentional and destructive way, it could immediately manifest into a mass die-off of the human population.
mRNA use should be a rare exception for extrordinary circumstances, for a single approved patient – not a “general rule” for the global for everything vaccine-related.
If we could only get the truth out to all the people I don’t think anyone would take it !!! So many people are still ignorant about this stuff.
Sara,
The deadwood piles up very high when Mother Nature is deprived of presenting a periodic season of “hard times” in order for Her to cull the herd of the ‘less capable (or bone-headed or deaf)’. We had it very easy in the past 50 years. No amount of “truth” will wake up ‘deadwood’. In the past, it simply got culled, a bit at a time. We are probably due for another culling “a lot at a time”, this time.
Methinks that Mother Nature will soon cash in her chips and you will witness a mass collection of delinquent and present “Darwin Awards” if something doesnt radically change to awaken the masses. So Life goes.
They know now with 100% certainty that the Pfizer vax had sd 40, which creates cancers that are accelerated (turbo). Dr. Peter McCullough and others are advocating that they be removed from the market. Yet, our pork has been injected with mRNA vax, and they’re beginning to vax cattle with it. It’s time to get your animal protein from local farmers who do not use this technology. Also, dairy cattle is being injected with Bovaers, which is toxic to the animal and humans all on the account that B Gates says that their passing gas is 6% of methane in our atmosphere. What about our garbage dumps then? Beavers will be in our dairy. They are literally paying farmers to give this to their dairy cows. This is beyond evil.
1 Like
Certainly, so what I created and published is a article for safe use of LNP and mRNA, by safe it means that all risk from the use of LNP and mRNA is removed using a in vitro to vivo in a no metal contact system approach, through this you first take a blood draw, then in the no-metal contact system the cultivation of the spike protein is performed, this cultivation and expression of the spike protein is then filtered using particle size separators and micro suction ports, this is then introduced into a saline solution for injection once the spike protein has reach a specific quantity, this removes all risk to the host from LNP and active mRNA by never introducing the host to these particles, there is zero risk of LNP causing neurological problems as they are not in the system of the host, this means they have no ability to cross the blood brain barrier, there is no risk of Myocarditis as it also is never introduced into the system and thus has no ability to enter the heart cell tissues, it also has no unregulated protein production as this in vitro system regulates it, which means no degeneration or unregulated resource use. The mRNA is also not introduced into the host and as such no risk of genome contamination, this means no transcription into the DNA.
Complete removal of all risk of LNP and mRNA use since literally none of this is entered into the body of the patient. Only the therapeutic aspect is utilized in the patients body, this system has no need for preservatives or adjuvants as it is made on call, this means no added chemicals.
I shared the entire text of the article minus the references but it is awaiting approval from a moderator.
Here is text from the article with references for each section in the actual article.
ABSTRACT
This article presents a novel approach for the application of lipid nanoparticle (LNP) and mRNA technologies,
focusing on the treatment of terminal cancers while minimizing risks to patient health. Our method isolates the
therapeutic component from its delivery system to prevent systemic exposure to LNP and mRNA to reduce as
many conflicts with biological components as possible using a particle model called Particle Progression.
KEYWORDS: LNP, mRNA, in vitro protein synthesis, terminal cancer, vaccine safety, myocarditis prevention, AI.
MATERIALS
In Vitro Preparation and Vaccine Formulation
• Lipid Nanoparticles (LNPs)
• mRNA
• Sterile Saline Solution
Microfluidic System for Metal-Free AI-assisted
Production
• Hardened Glass for microfluidic devices and
syringes
• Glass Syringes for blood collection
Monitoring and Quality Control
• Microscopy Equipment (implied for confocal or
fluorescence microscopy)
Separation and Purification
• Microchannels or Micro Suction Systems (made
from or using materials compatible with the process,
likely glass or another inert material)
METHODOLOGY
In Vitro Preparation
LNP and mRNA Introduction: Instead of direct
injection, the LNP and mRNA are introduced into a
controlled in vitro environment. This involves culturing
cells or using cell- free systems where the mRNA can be
translated into spike proteins without the risk of systemic
exposure.
Spike Protein Extraction: Once expressed, the spike
proteins are isolated from the cellular environment. This
step ensures that only the desired therapeutic components are utilized, significantly reducing the risk of unregulated
protein production.
Vaccine Formulation
Purification: The isolated spike proteins are then
purified to remove any cellular debris or other
contaminants.
Saline Solution: The purified proteins are mixed with a
sterile saline solution to create a vaccine or therapeutic
agent. This approach ensures that the final product does
not contain active LNP or mRNA but only the necessary
proteins or antigens.
In Vivo Administration
Injection: The prepared solution can then be
administered to the patient, introducing only the spike
proteins needed for immune response or therapeutic
effect, without the risks associated with live LNPs or
mRNA.
Risk Reduction
Blood-Brain Barrier Integrity: By avoiding direct
systemic circulation of LNPs and mRNA, this method
minimizes the chance of these particles crossing the
blood-brain barrier, thereby reducing potential
neurotoxic effects.
Synaptic Function: The absence of LNPs in the
bloodstream post-administration decreases the likelihood
of interference with neuronal communication or function. Myocarditis Risk: By not directly injecting LNPs, which
can sometimes lead to inflammation or immune
responses in heart tissue, the risk of myocarditis is
significantly reduced.
Resource Depletion: The controlled production of spike
proteins in vitro prevents the body from using its
resources inefficiently, thus avoiding the potential
depletion of vital components in the blood used for
protein synthesis.
Metal-free AI assisted System
Creating a metal-free system for the production,
monitoring, and delivery of LNP (Lipid Nanoparticle)
encapsulated mRNA vaccines using hardened glass
involves integrating several advanced technologies,
particularly in microfluidics, AI-driven automation, and
advanced microscopy.
SYSTEM COMPONENTS
Microfluidic Devices for LNP and mRNA Interaction
Hardened Glass Microfluidics: Develop microfluidic
devices from hardened glass to ensure no metal
contamination. Glass-based microfluidic systems have
been used for LNP production due to their durability and
compatibility with biological processes. These devices
would facilitate the precise mixing of lipid solutions with
mRNA in the presence of blood samples in vitro. The
glass should be treated to be biocompatible and inert to
biological materials.
Blood Collection and Mixing: Use glass syringes or
microfluidic devices for drawing blood to ensure no
metal contact. The blood would be introduced into the
microfluidic chamber where it mixes with LNPs
containing mRNA. The mixing should be controlled by
AI to optimize conditions like temperature, pH, and flow
rate for mRNA expression.
Monitoring and Quality Control with AI
AI Monitoring: Implement AI algorithms to monitor the
production of spike protein within the LNPs. This
involves real-time analysis of the mRNA translation
process by assessing protein expression levels. AI can use
data from spectroscopy or fluorescence-based detection
systems to determine when the desired PPM (parts per
million) of spike protein is achieved.
Image Analysis: Advanced microscopy techniques like
confocal or fluorescence microscopy can be used to
visualize protein expression directly in the microfluidics
setup. AI can analyze these images to quantify protein
production and ensure quality control.
Separation and Purification
Micro Suction System: After achieving the target spike
protein concentration, a micro suction system or a series
of microchannels could be used to remove excess LNPs,
mRNA, or cells. This system could employ size
exclusion or affinity-based separation techniques, enhanced by AI to control flow dynamics and optimize
separation efficiency.
Final Preparation and Delivery
Saline Mixing: Once purified, the spike protein would
be mixed with a non-toxic saline solution within the
same microfluidic environment to prepare for injection.
This step would be automated to ensure sterility and
precision in concentration.
Automation and Timing
AI Automation: AI would orchestrate the entire process
from blood mixing to final product preparation, ensuring
each step is executed with minimal human intervention
for speed and accuracy.
Approximate Timeframe
Blood to Protein Expression: Depending on the setup
and efficiency of mRNA translation, this could take
anywhere from 30 minutes to several hours.
Separation and Purification: This step might take 15
30 minutes with optimized AI algorithms. Preparation for
Injection: Mixing with saline might be completed in 5-10
minutes. Thus, the entire process from blood collection to
having an injectable solution could be potentially
optimized to be completed in under 2 hours.
Challenges and Considerations
Biocompatibility: Ensuring the glass and any other
materials used are biocompatible at every stage.
Sterility: Maintaining sterility throughout the process is
critical, especially when dealing with blood and protein
solutions.
Scale and Cost: While this system is designed for on
demand production, the cost of such sophisticated
equipment and the precision required could be high,
potentially limiting its immediate scalability.
Informative Discussion
When a synapse in the brain comes into direct contact
with a heavy metal, several adverse effects on synaptic
function can occur which supported by related research
and further understood through Particle Progression:
Disruption of Neurotransmitter Function: Heavy
metals like mercury can bind to and inhibit the function
of neurotransmitter receptors. This interference disrupts
the normal synaptic transmission, which is critical for
cognitive processes such as learning and memory. This
could potentially lead to impaired cognitive function.
Compromise of the Blood-Brain Barrier (BBB):
Exposure to heavy metals can weaken the integrity of the
blood-brain barrier, allowing these substances to enter
the brain more easily. Once in the brain, they increase
neurotoxicity by directly affecting neuronal structures,
including synapses. () Induction of Neuroinflammation:
Chronic exposure to heavy metals can result in persistent
neuroinflammation. This involves the activation of immune cells in the brain, leading to the release of
inflammatory mediators that can damage neurons and
disrupt synaptic functions, contributing to cognitive
dysfunction.
Impact on Neurotrophic Factors: Heavy metals can
alter the balance of neurotrophic factors like BDNF
(brain-derived neurotrophic factor), which are essential
for neuronal growth, survival, and plasticity. Any
disruption here can affect synaptic plasticity, which is
crucial for learning and memory.
This explanation is based on the mechanisms outlined in
the scientific literature regarding heavy metal exposure
and its impact on the brain’s synaptic function, is
identified using Particle Progression regarding the
presence of a heavy metal particle at a synapse.
The interaction between heavy metals and synaptic
function can significantly impact the electrical signals in
the brain that are responsible for various functions
including motor activity, cognitive thought, memory
access, and cholinergic signaling. Here’s how: Motor
Function: Motor functions are controlled by the precise
timing and coordination of electrical signals between
neurons. When heavy metals disrupt synaptic
transmission by binding to neurotransmitter receptors,
this can lead to improper signaling.
For instance, if the signal that should initiate muscle
movement is altered or blocked, motor control can be
affected, leading to issues like tremors or coordination
problems, which are seen in conditions like Parkinson’s
disease, where heavy metal exposure might play a role.
Cognitive Thought: Cognitive processes involve
complex networks of neurons communicating through
electrical and chemical signals. Heavy metals can
interfere with these processes by disrupting the normal
synaptic activity, which might alter thought processes.
For example, if the synaptic function is compromised,
the brain’s ability to process information efficiently could
be hindered, affecting reasoning, problem-solving, and
decision- making abilities.
Memory Access: Memory formation and retrieval
depend on synaptic plasticity, the ability of synapses to
strengthen or weaken over time in response to increases
or decreases in their activity. Heavy metals can impair
this plasticity by affecting neurotrophic factors like
BDNF, which are crucial for learning and memory. If
heavy metals interfere with synaptic plasticity, it could
lead to difficulties in forming new memories or
accessing existing ones, contributing to memory deficits.
Cholinergic Signaling: Cholinergic neurons use
acetylcholine as a neurotransmitter, which is vital for
attention, learning, and memory. The presence of heavy
metals can disrupt cholinergic signaling by altering the
function of acetylcholine receptors at the synapse or by damaging the cholinergic neurons themselves. This
disruption can lead to cognitive impairments because
cholinergic pathways are critical for cognitive function,
especially in areas like the hippocampus, which is
involved in memory formation.
In summary, when heavy metals come into contact with
synapses, they can interfere with the normal electrical
signaling pathways by disrupting neurotransmitter
function, altering neurotrophic support, inducing
inflammation, and compromising the integrity of brain
barriers. This interference can lead to broader
neurological effects, impacting the brain’s ability to
manage motor control, cognitive processes, memory, and
cholinergic functions, potentially leading to conditions
like cognitive decline or neurodegenerative diseases.
If cholinergic neurons that control the heart come into
direct contact with heavy metals, several detrimental
effects can occur, impacting the heart’s function through
the disruption of cholinergic signaling:
Disruption of Heart Rate Regulation: Cholinergic
neurons play a significant role in the parasympathetic
control of the heart, primarily through the release of
acetylcholine which slows down the heart rate. If heavy
metals interfere with these neurons, they could disrupt
the
normal release or function of acetylcholine,
potentially leading to an increase in heart rate or irregular
heartbeats due to the loss of parasympathetic influence.
Altered Cardiac Function: Since acetylcholine can also
affect the contractility of the heart, any interference by
heavy metals might alter how the heart muscle contracts,
potentially leading to inefficient pumping or arrhythmias.
This is because acetylcholine binds to muscarinic
receptors in the heart, reducing the force of contraction;
if this process is compromised, the heart’s efficiency
could be affected.
Neuroinflammation and Damage: As mentioned
previously, heavy metals can induce neuroinflammation.
In the context of cholinergic neurons controlling the
heart, this inflammation could lead to damage or
degeneration of these neurons, impairing their ability to
regulate heart function over time.
Compromised Neurotransmitter Release: Heavy
metals could directly affect the release of acetylcholine
from cholinergic neurons by disrupting vesicle function
or the synaptic machinery involved in neurotransmitter
release, which would further impair the heart’s
autonomic control.
Long-term Cardiovascular Health: Chronic exposure
to heavy metals affecting these neurons could contribute
to long-term cardiovascular issues, including increased
risk of heart disease, as the balance between the
sympathetic and parasympathetic nervous systems is
disrupted, leading to sustained changes in heart function. These effects are inferred from the general mechanisms
by which heavy metals impact cholinergic systems and
the specific role of cholinergic neurons in heart
regulation, as discussed in the scientific literature on
heavy metal neurotoxicity and neurotransmitter function.
Seizures: Can occur when the normal balance of
electrical activity in the brain is disrupted, leading to an
excessive and synchronized firing of neurons.
How heavy metal exposure might contribute to this
crossover or synchronization of electrical signals
between synapses, potentially leading to seizures:
Disruption of Neurotransmitter Balance
Excitatory vs. Inhibitory Imbalance: Heavy metals can
preferentially affect either excitatory (like glutamate) or
inhibitory (like GABA) neurotransmitters:
Excitatory Neurotransmitters: By inhibiting enzymes
like glutamine synthetase (which converts glutamate to
glutamine, thus reducing excitotoxicity) or by blocking
glutamate reuptake, metals can lead to an increase in
glutamate levels, enhancing excitatory activity.
Inhibitory Neurotransmitters: Heavy metals might
inhibit GABA synthesis or bind to GABA receptors,
reducing inhibitory control, which normally keeps
excitatory activity in check.
Neurotransmitter Release and Reuptake: As
described, heavy metals can disrupt the normal release,
receptor interaction, and reuptake of neurotransmitters.
This can result in an uncontrolled release of excitatory
neurotransmitters or a failure to terminate their action,
leading to hyperexcitability.
Electrical Signal Propagation
Ion Channel Dysregulation: Heavy metals can alter the
function of voltage-gated ion channels, particularly those
for sodium and potassium, which are crucial for action
potential generation and propagation:
Sodium Channels: If these channels are blocked or their
kinetics altered, neurons might fire more readily or with
less stimulus.
Potassium Channels: Impairment here can lead to
prolonged depolarization, making neurons more likely to
fire additional action potentials.
Membrane Potential Changes: The resting membrane
potential can be disturbed by heavy metals, making
neurons more excitable. If neurons are closer to their
firing threshold, less stimulation is needed to trigger an
action potential, increasing synchronized firing. Synaptic. Synchronization
Ephaptic Coupling: Heavy metals might change the
electrical environment between neurons, enhancing
ephaptic coupling where the electric field of one neuron’s
activity
directly
influences
another’s
without
neurotransmitter involvement. This can lead to
synchronized firing across neurons.
Gap Junctions: Although less common in mature brain
neurons,
gap junctions allow direct electrical
communication between cells. Heavy metals might alter
the regulation or function of these junctions, facilitating
the spread of electrical activity.
Seizure Initiation and Propagation
Kindling Phenomenon: Repeated exposure to metals
might lower the seizure threshold over time, a process
akin to kindling, where sub-threshold stimuli
progressively lead to seizures.
Microglial
Activation:
Heavy
metal-induced
inflammation can activate microglia, which release
cytokines that alter neuronal excitability, further
contributing to seizure initiation.
Oscillations and Networks: Normal brain activity
involves coordinated oscillations; heavy metals could
disrupt these, leading to pathological oscillations
characteristic of seizures where large groups of neurons
fire in unison.
Feedback Loops
Calcium Overload: Heavy metals can lead to calcium
influx, which, if unchecked, can perpetuate neuron
excitability, creating a feedback loop where more calcium
leads to more neurotransmitter release, further excitation,
and seizure persistence.
Neurotransmitter Cascades: The initial disruption by
heavy metals can set off a cascade of neurotransmitter
release, where one neurotransmitter triggers the release
of another, amplifying the excitatory signal.
In summary, heavy metals disrupt the delicate balance
between excitatory and inhibitory activity, alter ion
channel function, and change the electrical environment
in the brain, potentially leading to the abnormal
synchronization of neuronal activity that characterizes a
seizure. This complex interaction underscores the
importance of managing heavy metal exposure to prevent
such neurological complications.
Lipid Nano Particles and the Blood Brain Barrier
Lipid nanoparticles (LNPs): Are indeed very small,
typically ranging from 20 to 100 nanometers in diameter.
This size allows them to interact with biological systems
at a cellular level, including potentially crossing the
blood-brain barrier (BBB).
Here’s how this might work from a particle physics
perspective:
Crossing the Blood-Brain Barrier: Size and Surface
Charge
Size: LNPs’ nanoscale size facilitates passive diffusion or
transcytosis across the BBB. The smaller the particle, the
more likely it can pass through tight junctions of
endothelial cells or be taken up by them.
Surface Charge: LNPs can be designed with specific
surface charges or coatings that can interact with cell
membranes, possibly modulating the BBB permeability.
Interaction with Endothelial Cells: LNPs might bypass
the BBB by adsorptive-mediated transcytosis, where
particles bind to receptors on the luminal side of
endothelial cells and are transported across to the brain.
Particle Physics Perspective
Quantum Tunneling: At the quantum level, particles
could theoretically tunnel through biological membranes
if the barrier’s energy is less than the particle’s kinetic
energy, although this effect is negligible for LNPs due to
their size and mass.
Interaction with Brain Tissue
Nucleus Entry: If LNPs manage to enter the nucleus,
they could potentially interact with DNA or RNA.
However, the nuclear envelope’s selective permeability
typically prevents this, unless facilitated by specific
mechanisms like nuclear transport pathways.
Damage Potential
Direct Damage: LNPs could cause oxidative stress or
inflammation if they accumulate in brain tissue, leading
to cellular damage or apoptosis.
Indirect Damage: By altering gene expression if they
carry nucleic acids, they could cause long-term changes
in brain function.
Impact on Synapses
Synaptic Function Disruption
Neurotransmitter Release: LNPs might interfere with
vesicular trafficking or neurotransmitter release if they
interact with synaptic vesicles or the synaptic cleft.
Receptor Interaction: They could bind to or block
neurotransmitter receptors, altering signal transmission.
The particle’s surface chemistry would be crucial here.
Particle Physics Considerations
Binding Forces: The electromagnetic forces (van der
Waals, electrostatic interactions) between LNPs and
synaptic components could lead to aggregation or
dispersion, affecting synaptic signaling.
Interference with Ion Channels: If LNPs have charges
or ions, they might influence the electric potential across neuron membranes, potentially affecting ion channel
function.
Possible Scenarios
Beneficial Use: LNPs could be designed for targeted
drug delivery to the brain, offering therapeutic benefits
for neurological disorders by delivering drugs directly to
affected areas.
Adverse Effects
Non-specific Binding: LNPs might bind non-specifically
to various brain components, leading to unexpected
biological responses.
Long-Term Effects: The accumulation of LNPs over
time could lead to chronic inflammation or
neurodegenerative processes if not biodegradable or if
clearance mechanisms are overwhelmed.
Research Gaps: There’s still much to learn about how
LNPs interact with complex biological systems at the
nano-scale. Research into their long-term effects,
biocompatibility, and degradation in neural tissues is
ongoing.
Reverse Transcription: mRNA encapsulated in lipid
nanoparticles (LNPs) is used in an in vitro cell culture to
produce spike proteins. The active mRNA and LNPs are
filtered out, leaving only the spike proteins in a saline
solution for injection.
Risk Reduction for Myocarditis
Elimination of Direct LNP Exposure: By not injecting
LNPs directly into the patient, the primary risk factor for
myocarditis associated with LNP delivery systems is
removed. LNPs can trigger an immune response leading
to inflammation in various tissues, including the heart.
The proposed method involves extracting spike proteins
in vitro, thus avoiding this direct exposure.
Controlled Protein Synthesis: Since the spike proteins
are produced outside the body in a controlled
environment, there’s no unregulated or excessive protein
production within the patient’s body that could lead to an
immune response potentially causing myocarditis. The
body only receives the final, purified protein product,
which minimizes the chance of an inflammatory reaction
in the heart muscle.
Reduction in Adjuvant-Related Risks: Traditional
vaccines often include adjuvants to boost immune
response, some of which might increase the risk of
myocarditis. By only introducing purified spike proteins
in saline, this risk is further diminished since no
additional chemical compounds or biological materials
that could provoke an inflammatory response are
included.
Avoidance of Systemic Immune Activation: The method avoids the systemic introduction of foreign nucleic acids, which can lead to widespread immune
activation. When LNP- encapsulated mRNA is used
directly in vivo, it can lead to systemic cytokine release,
potentially affecting the heart. Here, the immune system’s
interaction is with a protein antigen in a controlled
manner, reducing the likelihood of an adverse systemic
reaction.
Estimated Risk Reduction of Myocarditis
Theoretical Risk Reduction: If we consider the direct
causes of myocarditis linked to LNP. and mRNA
vaccines, this approach could theoretically reduce the risk
to near zero for myocarditis directly caused by these
components.
However, this is under ideal conditions where
No LNP or mRNA enters the patient’s system post
administration.
The spike protein is pure and devoid of any contaminants
or residual LNPs.
The immune response is directed strictly against the spike
protein without broader inflammatory effects.
Practical Considerations
Implementation Efficacy: Real-world application might
not achieve perfect conditions, so there could be minor
risks from trace contaminants or unforeseen immune
responses to the spike protein itself.
Individual
Variability:
Genetic,
health,
and
environmental factors in patients could still lead to rare
cases of myocarditis even with this method.
Given these points, while the risk of myocarditis could
be dramatically reduced, stating an exact percentage is
speculative. However, if executed correctly, this method
should significantly lower the occurrence of myocarditis
compared to traditional LNP-mRNA vaccines,
potentially reducing the risk by over 90% when
compared to current statistics on myocarditis post
vaccination.
Risk of Reverse Transcription (RT) to DNA
Understanding Reverse Transcription: Reverse
transcription is the process by which RNA is converted
into DNA by the enzyme reverse transcriptase. This is a
natural process in retroviruses but not in typical human
cells. However, under certain conditions, human cells
might use their own enzymes (like LINE-1 reverse
transcriptase) or possibly take up viral reverse
transcriptase to convert RNA into DNA.
Risk Reduction to 0%
mRNA and LNP Filtration: By filtering out the mRNA
and LNPs, you theoretically eliminate the substrate
(mRNA) that could potentially be reverse transcribed into
DNA.
Spike Protein Only: If only the spike protein is
delivered, there’s no RNA available to be reverse transcribed. Proteins do not have the capacity for reverse
transcription; they are not nucleic acids.
Saline Solution: Saline is simply a salt solution, and it
does not contain any components that could facilitate or
initiate reverse transcription.
Factors Influencing Risk
Absence of mRNA: Since the mRNA is not present in
the final injectable product, the primary concern for
reverse transcription is removed. The spike protein itself
cannot undergo reverse transcription.
No Viral Components: Assuming no viral particles or
components that could introduce or activate reverse
transcriptase are present, the risk of reverse transcription
would indeed be significantly reduced.
Human Cellular Machinery
Endogenous RT: Even without the mRNA, human cells
have some endogenous reverse transcriptase activity,
especially from LINE-1 elements. However, this activity
is generally low and not directly associated with the spike
protein itself. The spike protein would need to interact
with or induce mechanisms that are not typically part of
its function.
Experimental Evidence: Current scientific evidence
does not support the notion that spike proteins by
themselves can induce reverse transcription. Studies
focusing on mRNA vaccines have found no significant
integration of vaccine-derived RNA into human DNA.
Given the conditions described
Risk of Reverse Transcription: The risk of reverse
transcription into DNA from the spike protein in saline
would be negligible to zero because: There’s no RNA to
transcribe. The spike protein does not possess nucleic
acid sequences. The saline solution does not introduce
any reverse transcriptase or similar enzymes.
Contraindications
Avoid Direct Use with Certain Pathogens: Do not use
this method for pathogens like bird flu where the spike
proteins could facilitate binding and infection. The
introduction of proteins that pathogens can easily bond to
could exacerbate infection risks.
CONCLUSION
This approach to using LNP and mRNA technologies
offers a safer alternative by isolating the therapeutic
component from its potentially harmful delivery system.
This method should be considered for application in
which immenent death may occur such as in cases of
terminal cancer, under stringent clinical oversight. Note:
This system is experimental and should be implemented
with full ethical review, informed consent, and under
conditions where alternatives are not viable or have been exhausted. Continuous monitoring for unforeseen
effects is crucial.
The risk of reverse transcription into DNA from the spike
protein in saline would be negligible to zero because:
There’s no RNA to transcribe. The spike protein does not
possess nucleic acid sequences. The saline solution does
not introduce any reverse transcriptase or similar
enzymes.
For medical applications, their interaction with the brain
requires careful study to understand both the potential
benefits and risks, particularly from a particle physics
standpoint where the interplay of forces and particle
behavior could dictate biological outcomes. Introduce of
chemicals or particles of any kind, makes contact with
brain tissue or synapses it can and will alter the normal
functions of the brain to include energy transfer and
electrostatic charges of those systems.
This system would represent a highly advanced
application of biotechnology, microfluidics, and AI,
aiming for personalized medicine where vaccines or
therapies could be tailored in real-time to an individual’s
biological response.
However, it would require significant research,
development, and regulatory approval before practical
implementation. I suggest that you do not use
florescence, as this is a chemical process that is not
actually required. Multi lensed confocal Microscopy
could be used.
Estimation of Risk Reduction
Contaminants: By using a closed, sterile system with
glass and AI control, the risk of contamination could
theoretically be reduced to near zero. This eliminates the
need for preservatives like thimerosal, thus removing any
associated risk, although no numeric data directly
quantifies this reduction. -Risk reduced to near 0%.
Heavy Metals: Eliminating the use of aluminum salts or
any other heavy metal-based adjuvants reduces the risk to
0% since these are not part of the proposed method. -Risk reduced to 0%.
Foreign DNA: If the proposed method ensures no
residual DNA from production processes, the risk would
be reduced from the reported 6 to 470 times over the
limit to 0%, assuming perfect execution of the process.
This would eliminate concerns about genomic integration
or genetic disruptions. -Risk reduced to 0%.
Lipid Nanoparticles (LNPs): Removing LNPs from the
vaccine composition would eliminate all risks associated
with LNPs, including potential myocarditis, neurological
conditions, immune responses or issues with clearance.
Since LNPs are not used, this risk is reduced to 0%.
-Risk reduced to 0%.
ACKNOWLEDGEMENTS
We would like to express our sincere gratitude to the
following individuals and entities whose contributions
were instrumental in the development and creation of
this article:
Our acknowledgements extend to the researchers and
scientists whose previous work laid the foundation for
our novel approach. The literature on in vitro protein
synthesis, lipid nanoparticle technology, mRNA vaccines
and the risks associated with heavy metals and
neurotoxicity has been pivotal in our methodological
development.
To the anonymous reviewers who provid constructive
feedback that significantly improves the quality and
clarity of this manuscript and others like it, we offer our
thanks. Most importantly I would like to acknowledge
the ethical review boards and regulatory bodies for their
oversight, which ensures that all ethical considerations
were met, especially given the experimental nature of
this work and its implications for human health.
I am deeply grateful to the editorial team and reviewers
of European Journal of Biomedical and Pharmaceutical
Sciences for considering this manuscript for publication.
Your commitment to advancing scientific knowledge in
this field is commendable, and I am honored to
contribute to your esteemed journal. Thank you for
providing a platform that fosters innovative research,
new technology and supports the dissemination of novel
findings.